Tianjin, Shandong, and Hainan Provinces Announce VBP Backup Suppliers for Round 8
Tianjin, Shandong, and Hainan provinces in China have released their lists of backup suppliers following...
Policy / Regulatory
NMPA Extends Public Feedback Period for ‘Drug Standardization Management Measures’ in China
The National Medical Products Administration (NMPA) in China has announced an extension to the public...
Anhui and Qinghai Provinces Update BMI Chronic Disease Drug Lists for Outpatient Reimbursement
The healthcare security bureaus of Anhui and Qinghai provinces in China have separately released notifications...
China’s CDE Releases 69th Batch of Generic Chemical Reference Preparations for Public Review
The Center for Drug Evaluation (CDE) in China has released the 69th batch of chemical...
China’s Regulatory Bodies Unveil Guidelines to Strengthen Supervision of Medical Aesthetic Industry
The State Administration for Market Regulation, National Health Commission, National Administration of Traditional Chinese Medicine,...
NMPA Transitions Desloratadine, Loratadine, Ambroxol, and Naproxen to OTC Status
The National Medical Products Administration (NMPA) has indicated on its website that four products will...
Chinese Authorities Launch Special Campaign to Combat Fraud in Medical Insurance
The National Healthcare Security Administration, Supreme People’s Procurator, Ministry of Public Security, Ministry of Finance,...
China’s CDE Unveils Technical Guidelines for Stem Cell Products and Immunotherapy in Chronic Hepatitis B
The Center for Drug Evaluation (CDE) has released a series of Technical Guidelines aimed at...
NMPA Mandates Label Updates for 11 Drug Varieties Including Black Box Warnings
The National Medical Products Administration (NMPA) has released 10 notifications regarding revisions to package inserts...
Jiangsu Initiates Price Negotiations for Provincial Stock Drugs, Addresses Shortages
The Jiangsu Public Resource Trading Platform has released a notification indicating the commencement of price...
China’s NHC Advances Enhanced Recovery After Surgery (ERAS) Protocols Nationwide
The National Health Commission (NHC) has released a notification with the goal of promoting enhanced...
NMPA’s 2022 Drug Supervision Report: Clinical Trials and Market Filings on the Rise
The National Medical Products Administration (NMPA) has released its “Annual Drug Supervision and Administration Statistics...
National Center Reports Increase in Medical Device Adverse Event Reports for 2022
The National Center for Adverse Event Monitoring has released its national annual report regarding the...
China’s NMPA, MPS, and NHC Announce Updates to Narcotics and Psychotropic Substances Catalog
The National Medical Products Administration (NMPA), Ministry of Public Security, and National Health Commission have...
Hainan Introduces Management Regulations for Urgently Needed Import Drugs and Devices in Boao Lecheng
The Hainan provincial government has issued a Notice on the Management Regulations for Clinically Urgently...
NHC Proposes Updates to Access Standards for Class A and B Medical Equipment
The National Healthcare Commission (NHC) has released two proposed updates to the Access Standards for...
Round 8 VBP Tender Results: RMB 3.775 Billion Awarded Across 152 Manufacturers
The official results of Round 8 of China’s national Volume-Based Procurement (VBP) tender program have...
Hubei Implements Inter-Provincial VBP Tender Results for Pacemakers
The Hubei provincial Drug and Instrument Procurement Platform has issued a notice regarding the implementation...
NHC Report: Performance Assessment of National Class 2 Public Hospitals in 2021
The National Health Commission (NHC) has released the “Report on the National Monitoring and Analysis...
Hebei Leads Sanming Alliance in Launching 8th VBP for 19 Medical Consumables
The Hebei medical drug and device centralized procurement center has announced the start of the...